4.2 Article

A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history

Related references

Note: Only part of the references are listed.
Review Oncology

Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal

Andrea Tinelli et al.

CANCER AND METASTASIS REVIEWS (2010)

Article Medicine, General & Internal

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.

Peter C. Fong et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Editorial Material Medicine, General & Internal

Synthetic Lethality -- A New Direction in Cancer-Drug Development.

J. Dirk Iglehart et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Oncology

Functional assays for classification of BRCA2 variants of uncertain significance

Daniel J. Farrugia et al.

CANCER RESEARCH (2008)

Article Medicine, General & Internal

Variation of breast cancer risk among BRCA1/2 carriers

Colin B. Begg et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)

Article Multidisciplinary Sciences

Resistance to therapy caused by intragenic deletion in BRCA2

Stacey L. Edwards et al.

NATURE (2008)

Article Genetics & Heredity

The emerging landscape of breast cancer susceptibility

Michael R. Stratton et al.

NATURE GENETICS (2008)

Article Biochemistry & Molecular Biology

DNA damage hypersensitivity in cells lacking BRCA2:: a review of in vitro and in vivo data

T Hay et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2005)

Article Multidisciplinary Sciences

BRCA2 BRC motifs bind RAD51-DNA filaments

VE Galkin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Biochemistry & Molecular Biology

BRCA2 is required for homology-directed repair of chromosomal breaks

ME Moynahan et al.

MOLECULAR CELL (2001)